HER2-positive breast cancers are rare amongst BRCA mutation carriers. No data exist regarding clinicopathological characteristics and prognosis of this subgroup of patients.
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer / Viansone, A; Pellegrino, B; Omarini, C; Pistelli, M; Boggiani, D; Sikokis, A; Uliana, V; Zanoni, D; Tommasi, C; Bortesi, B; Bonatti, F; Piacentini, F; Cortesi, L; Camisa, R; Sgargi, P; Michiara, M; Musolino, A. - In: THE BREAST. - ISSN 0960-9776. - 65:(2022), pp. 145-150. [10.1016/j.breast.2022.07.012]
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer
Pellegrino, B;Boggiani, D;Sikokis, A;Uliana, V;Tommasi, C;Musolino, A
Conceptualization
2022-01-01
Abstract
HER2-positive breast cancers are rare amongst BRCA mutation carriers. No data exist regarding clinicopathological characteristics and prognosis of this subgroup of patients.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
